We are currently updating the content of our website to meet the Americans with Disabilities Act Title II requirements. We will be back soon!
Post date: Apr 20, 2017 4:28:06 PM
Our paper in collaboration with the Ghobrial lab at the Harvard's Dana Farber Cancer Institute is out! In this study we profiled the ECM composition of the bone marrow from patients with monoclonal gammopathy of undetermined significance (MGUS), newly diagnosed and relapsed MM and compared it to healthy donor-derived bone marrow. You can read the full article here.